~~<i id='2CC992814B'><strike id='2CC992814B'><tt id='2CC992814B'><pre id='2CC992814B'></pre></tt></strike></i>~~

Home» explore» Wikipedia

Wikipedia

author：comprehensive 2025-09-29 07:26:13 Page View：4

Monica Bertagnolli -- health policy coverage from STAT — NIH Director Monica Bertagnolli Kevin Dietsch/Getty Images

WASHINGTON — President Biden has promised to require fair prices from drugmakers that use federally funded research — and now, in a major recent move, said he’ll trigger government “march-in” on patents for drugs that run afoul of that goal.

“It’s a simple principle. You shouldn’t pay the highest price in the world for drugs that your tax dollars have already helped create,” Biden said last month as he touted the move at the National Institutes of Health.

But the new NIH director, locked in the center of this debate, isn’t taking any big steps yet.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc
Next article： Moonlake's readout produced a cash windfall. Risks remain

comprehensive

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

FILE-Abortion-rightsprotestersfillIndianaStatehousecorridorsandcheeroutsidelegislativechambers,Frida

UCB departs biotech trade group BIO

AdobeWASHINGTON— UCBleftBIOattheendof2023,thesecondmajormembercompanytoexitafterPfizerpulledoutaswel

How one medical school became remarkably diverse

ThefirstclassattheUniversityofCalifornia,Davismedicalschool,in1972,waspredominantlywhiteandmale.Chri

Cytokinetics CEO stresses company can launch heart drug on its own

CytokineticsCEORobertBlumspokeThursdayatatalkduringSTAT’sBreakthroughSummitWestinSanFrancisco.SarahG